Medicare announces lower prices on 10 common, high-cost drugs - NBC News
Aug 15, 2024 · The Biden administration said Thursday that it had reached an agreement with drugmakers to lower prices on the 10 costliest prescription drugs under Medicare.
Eliquis and Jardiance among 10 drugs up for Medicare price ... - NBC News
Aug 29, 2023 · The Centers for Medicare and Medicaid Services on Tuesday announced the first 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act, a critical...
FDA approves first generics of Eliquis | FDA - U.S. Food and …
The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with ...
First generics to Bristol-Myers and Pfizer's Eliquis are here.
Dec 26, 2019 · The FDA has approved the first two generics to blockbuster blood thinner Eliquis. But patent suits by developer Bristol-Myers Squibb might prevent the copycats' launches until late 2026. (Bristol...
Apixaban No Better Than Aspirin for Preventing Stroke ...
Feb 7, 2024 · More than a decade ago, the anticoagulant apixaban, trade name Eliquis, was shown to be superior to aspirin for preventing recurrent stroke in patients with a heart condition called atrial fibrillation.
NHS England recommends generic apixaban over edoxaban for …
Jan 31, 2024 · Generic apixaban has been recommended by NHS England over the previous first choice, edoxaban (Lixiana; Daiichi Sankyo), as a preferred direct-acting oral anticoagulant (DOAC) for the treatment of atrial fibrillation (AF) in new patients.
Late-Breaking Research Provides ‘Shocking’ Insights Into AFib ...
Nov 8, 2023 · New late-breaking science from AHA 2023 sheds light on new treatments for patients with atrial fibrillation (AFib). In ARTESIA, the results of which were also published in the New England Journal of Medicine, patients with subclinical AFib who were treated with apixaban (5 mg/twice daily) were 37% less likely to have a stroke or systemic ...
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
Nov 12, 2023 · In this trial involving patients with risk factors for stroke who were found to have subclinical atrial fibrillation, apixaban resulted in a lower risk of stroke or systemic embolism than...
Bristol Myers, Pfizer score another win in their Eliquis patent …
Sep 7, 2021 · The U.S. Court of Appeals for the Federal Circuit has upheld a prior win for the companies covering two Eliquis patents—the drug’s composition of matter patent and a formulation patent.
Asundexian versus Apixaban in Patients with Atrial Fibrillation
Sep 1, 2024 · Among patients with atrial fibrillation at risk for stroke, treatment with asundexian at a dose of 50 mg once daily was associated with a higher incidence of stroke or systemic embolism than...
- Some results have been removed